Corticostatin, human TFA
Corticostatin, human (Human Neutrophil Peptide-4) TFA is an antimicrobial peptide with demonstrated antiviral activity. Corticostatin, human TFA can kill Escherichia coli, Streptococcus faecalis, and Candida albicans. Corticostatin, human (HNP-4) TFA is more bactericidal against Gram-negative bacteria than any of HNP-1-3. Corticostatin, human TFA can be isolated from the azurophil granule fraction of discontinuous Percoll gradients.
For research use only. We do not sell to patients.
- Formula: C159H256F3N49O45S6.xC2HF3O2
- Molecular Weight:3709.43 (free base)
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Chemical Information
-
Molecular Weight 3709.43 (free base)
-
Formula C159H256F3N49O45S6.xC2HF3O2
-
Synonyms
Human Neutrophil Peptide-4 TFA
-
Sequence
Val-Cys-Ser-Cys-Arg-Leu-Val-Phe-Cys-Arg-Arg-Thr-Glu-Leu-Arg-Val-Gly-Asn-Cys-Leu-Ile-Gly-Gly-Val-Ser-Phe-Thr-Tyr-Cys-Cys-Thr-Arg-Val (Disulfide bridge:Cys2-Cys30,Cys4-Cys19,Cys9-Cys29)
-
Sequence Shortening
VCSCRLVFCRRTELRVGNCLIGGVSFTYCCTRV (Disulfide bridge:Cys2-Cys30,Cys4-Cys19,Cys9-Cys29)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Density Gradient Centrifugation-Based Cell Fractionation (Cell Enrichment Sorting)
Density gradient centrifugation enriches cells by buoyant density: cells sediment during centrifugation until they reach a medium layer or interface compatible with their density, allowing mononuclear cells, granulocytes, erythrocytes, and density-defined subpopulations to be recovered from separate bands or layers. Classic blood-cell applications include Ficoll/sodium-metrizoate or Ficoll-Hypaque enrichment of peripheral blood mononuclear cells, Percoll subfractionation of PBMC and T-cell populations, and Percoll-based neutrophil isolation from whole blood or leukocyte-enriched suspensions. The readout is the physical recovery of enriched cell bands, followed by cell counting, morphology, viability, and immunophenotyping to determine yield, purity, and suitability for downstream assays.
-
Gram Staining of Tissue Sections
Gram staining of tissue sections is a histochemical technique used to differentiate Gram-positive and Gram-negative bacteria within histological specimens based on differences in bacterial cell wall structure and dye retention, adapted from classical bacteriological Gram staining into tissue-compatible “histological Gram stain” variants. In tissue applications, modifications of the Brown-Hopps and Brown-Brenn methods are commonly used to improve differentiation of microorganisms embedded within host connective tissue and to reduce overstaining or loss of Gram-negative signal, which are known limitations of earlier approaches. The principle relies on crystal violet-iodine complex retention in Gram-positive organisms and subsequent decolorization and counterstaining steps that allow contrast visualization of Gram-negative organisms against tissue background.
Purity & Documentation
References
[1]. Ehmann D, et al. Fragmentation of Human Neutrophil α-Defensin 4 to Combat Multidrug Resistant Bacteria. Front Microbiol. 2020 Jun 3;11:1147. [Content Brief]
[2]. Wilde CG, et al. Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family. J Biol Chem. 1989 Jul 5;264(19):11200-3. [Content Brief]
[3]. Loffredo MR, et al. Antimicrobial peptides for novel antiviral strategies in the current post-COVID-19 pandemic. J Pept Sci. 2024 Jan;30(1):e3534. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)